<DOC>
	<DOCNO>NCT02154763</DOCNO>
	<brief_summary>This pilot study randomize , control , double-blinded format evaluate ability local anesthetic , Ropivacaine , decrease pain gastric bypass surgery . The drug administer abdomen bariatric bypass surgery . After surgery , patient receive Ropivacaine compare without Ropivacaine determine effect reduce pain , recovery lung function , ability walk , quality life recovery .</brief_summary>
	<brief_title>The Use Intraperitoneal Ropivacaine Bariatric Bypass Surgery</brief_title>
	<detailed_description />
	<mesh_term>Ropivacaine</mesh_term>
	<criteria>Patients undergo RouxenY gastric bypass surgery ; Patients able tolerate general anesthetic pneumoperitoneum ; Patients able provide inform consent surgery ; Patients age 18 year ; Chronic pain patient ( patient take preoperative opioids ) include Patient undergo plan Sleeve Gastrectomy ( intaop conversion Sleeve Gastrectomy delivery intraperitoneal ropivacaine include analyzed use intentiontotreat approach ) Patients allergy local anesthetic Patients severe underlie cardiovascular disease ( ie : congestive heart failure , conduction abnormality , ischemic heart disease ) Patients chronic renal disease Stage 3 great ( Creatinine clearance le 60mL/hr ) Patients hepatic dysfunction ChildPugh Class B C Patients previous foregut surgery include esophageal , gastric , liver , pancreas resection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>Bariatric surgery</keyword>
	<keyword>Bariatrics</keyword>
	<keyword>Local anesthetic</keyword>
	<keyword>Ropivacaine</keyword>
	<keyword>Intraperitoneal</keyword>
</DOC>